NLS Pharma is a clinical-stage drug development company. Our R&D Focus is based on a strong scientific understanding of neurobehavioral and neurocognitive disorders and their pharmacognosia. Our patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
View Top Employees from NLS Pharma AGWebsite | http://www.nls-pharma.com |
Ticker | NLSP |
Revenue | $34.2 million |
Employees | 6 (2 on RocketReach) |
Founded | 2015 |
Address | 6 The Cir, Zurich, Zurich 8058, CH |
Phone | +41 44 512 21 50 |
Fax | +41 41 618 80 09 |
Industry | Pharmaceuticals, Management Consulting, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular NLS Pharma AG employee's phone or email?
The NLS Pharma AG annual revenue was $34.2 million in 2023.
Eric Konofal is the Chief Scientific Officer of NLS Pharma AG.
2 people are employed at NLS Pharma AG.
NLS Pharma AG is based in Zurich, Zurich.
The NAICS codes for NLS Pharma AG are [3254, 32, 325].
The SIC codes for NLS Pharma AG are [28, 80, 283].